Evidence map›Paper›PMID 39151945›Full record

ArticleLife science alliance2024

Enhancing uterine receptivity for embryo implantation through controlled collagenase intervention.

Eldar Zehorai, Tamar Gross Lev, Elee Shimshoni, Ron Hadas, Idan Adir, Ofra Golani, Guillaume Molodij, Ram Eitan, Karl E Kadler, Orit Kollet and 4 more

Abstract read
In one paragraph

Article in Life science alliance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Eldar ZehoraiDepartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.
Tamar Gross LevDepartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.
Elee ShimshoniDepartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0003-3057-5393
Ron HadasDepartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.
Idan AdirDepartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.
Ofra GolaniLife Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
Guillaume MolodijLife Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-2196-5034
Ram EitanGynecologic Oncology Division, Helen Schneider Hospital for Women, Rabin Medical Center; Petah-Tikva and The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Karl E KadlerWellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.ORCID 0000-0003-4977-4683
Orit KolletDepartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-4912-4579
Michal NeemanDepartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-6296-816X
Nava DekelDepartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.
Inna SolomonovDepartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel inna.solomonov@weizmann.ac.il.ORCID 0000-0003-2486-1350
Irit SagiDepartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel irit.sagi@weizmann.ac.il.ORCID 0000-0001-5595-5515

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ineffective endometrial matrix remodeling, a key factor in infertility, impedes embryo implantation in the uterine wall. Our study reveals the cellular and molecular impact of human collagenase-1 administration in mouse uteri, demonstrating enhanced embryo implantation rates. Collagenase-1 promotes remodeling of the endometrial ECM, degrading collagen fibers and proteoglycans. This process releases matrix-bound bioactive factors (e.g., VEGF, decorin), facilitating vascular permeability and angiogenesis. Collagenase-1 elevates embryo implantation regulators, including NK cell infiltration and the key cytokine LIF. Remarkably, uterine tissue maintains structural integrity despite reduced endometrial collagen fiber tension. In-utero collagenase-1 application rescues implantation in heat stress and embryo transfer models, known for low implantation rates. Importantly, ex vivo exposure of human uterine tissue to collagenase-1 induces collagen de-tensioning and VEGF release, mirroring remodeling observed in mice. Our research highlights the potential of collagenases to induce and orchestrate cellular and molecular processes enhancing uterine receptivity for effective embryo implantation. This innovative approach underscores ECM remodeling mechanisms critical for embryo implantation.

Indexed as

CollagenasesEmbryo ImplantationUterusAnimalsCollagenEmbryo TransferEndometriumExtracellular MatrixFemaleHumansMiceMice, Inbred C57BLPregnancyVascular Endothelial Growth Factor ACollagencollagenase 1CollagenasesVascular Endothelial Growth Factor A

Identifiers

PMID39151945
PMCPMC11329778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.